However, the combination of PD-1 blockade and lenalidomide mediated the highest specific lysis of primary AML cells and significantly enhanced IL-2 secretion (Fig. 6B–D; Fig. S3). This evidence concerns the gene IL2 and acute myeloid leukemia.